365 results on '"Bidoli E"'
Search Results
102. Time trends in infectious disease mortality in Italy: 1969-1999 | Andamenti della mortalità per malattie infettive in Italia: 1969-1999
- Author
-
Serraino, D., Bidoli, E., Piselli, P., Angeletti, C., Bruzzone, S., Pappagallo, M., vincenzo puro, Girardi, E., Lauria, F., and Ippolito, G.
103. Analysis of infectious disease mortality in Italy,Analisi della mortalità per malattie infettive in Italia
- Author
-
Angeletti, C., Piselli, P., Bidoli, E., Bruzzone, S., vincenzo puro, Girardi, E., Ippolito, G., and Serraino, D.
104. Comparison of two different strategies for early diagnosis of cervical neoplasia in the North of Italy: Hospital-based and outpatient clinic-based screening
- Author
-
silvia franceschi, Gorga, G., Bidoli, E., Talamini, R., and Manfrin, G.
105. CONTROLLED CASE STUDY ON CONSUMPTION OF NUTRITIONAL FIBRES AND TUMOURS OF PANCREAS IN ITALY
- Author
-
Bidoli, E., Pelucchi, C., Zucchetto, A., Eva Negri, Dal Maso, L., Polesel, J., Boz, G., Montella, M., Franceschi, S., Serraino, D., La Vecchia, C., and Talamini, R.
106. The influence of reproductive and hormonal factors on thyroid cancer in women
- Author
-
Franceschi, S., Fassina, A., Talamini, R., Mazzolini, A., Vianello, S., Bidoli, E., Cizza, G., and Carlo La Vecchia
- Subjects
Adult ,Menarche ,Age Factors ,Middle Aged ,Abortion, Spontaneous ,Parity ,Sex Factors ,Italy ,Pregnancy ,Case-Control Studies ,Humans ,Female ,Thyroid Neoplasms ,Menopause ,Gonadal Steroid Hormones ,Aged - Abstract
We conducted a study on 165 women with thyroid cancer and 214 hospital controls in order to investigate the role of reproductive and hormonal factors in the aetiology of thyroid cancer. Late age at menarche (Relative risk (RR) for menarche at greater than or equal to 14 vs less than or equal to 11 = 2.8), menstrual irregularity (RR = 1.7), late age at first birth (RR for first birth at greater than or equal to 28 vs less than or equal to 21 = 2.4) and at last birth (RR for last birth greater than or equal to 30 vs less than 30 = 2.2) significantly increased the risk of the development of thyroid cancer both in premenopausal and postmenopausal women. Parity was, in the present study rather inconsistently related to disease status whereas voluntary abortions and miscarriages were completely unrelated. A non significant increasing risk was observed with age at menopause older than 50, and with the use of oral contraceptives in premenopausal women. The mechanism of action of female hormones on the thyroid gland remains largely obscure, but the observation that age at first and, perhaps, subsequent pregnancies may be relevant points to an interplay of reproductive factors (and, possibly, their hormonal correlates) more complex than previously suggested.
107. Neoplastic pericarditis: comparison of different therapeutic approaches
- Author
-
Lestuzzi, C., Bidoli, E., Viel, E., Macor, F., Buonadonna, A., Gian Luigi Nicolosi, Veronesi, A., and Meneguzzo, N.
108. Sentieri-epidemiological study of residents in national priority contaminated sites: Mortality, cancer incidence and hospital discharges,Sentieri-studio epidemiologico nazionale dei territori e degli insediamenti esposti a rischio da inquinamento: Mortalità, incidenza oncologica e ricoveri ospedalieri
- Author
-
Ancona, C., Ascoli, V., Bastone, A., Beccaloni, E., Benedetti, M., Bianchi, F., Biggeri, A., Binazzi, A., Bruno, C., Cadum, E., Caranci, N., Carboni, C., Carere, M., Catelan, D., Cernigliaro, A., Comba, P., Conti, S., Corfiati, M., Demaria, M., Santis, M. D., Falleni, F., Fazzo, L., Forastiere, F., Goldoni, C. A., Grisotto, L., Iavarone, I., Leonardi, M., Manno, V., Marcello, I., Marinaccio, A., Marsili, G., Martuzzi, M., Minelli, G., Minichilli, F., Mitis, F., Musmeci, L., Pasetto, R., Piccardi, A., Pirastu, R., Santoro, M., Scaini, F., Soggiu, M. E., Zona, A., Autelitano, M., Benfatto, L., Bonelli, L., Bianconi, F., Bidoli, E., Buzzoni, C., Candela, G., Cocchioni, M., Coviello, E., Cremone, L., Crocetti, E., Tos, A. P. D., Falcini, F., Federico, M., Ferretti, S., Fusco, M., Giacomin, A., Gola, G., Guzzinati, S., Rosa, F. L., Lillini, R., Madeddu, A., Magoni, M., Mangone, L., Maspero, S., Maule, M., Mazzoleni, G., Merletti, F., Michiara, M., Minerba, S., Nicita, C., Pannozzo, F., Piffer, S., Ricci, P., Carlotta Sacerdote, Sciacca, S., Sechi, O., Serraino, D., Stracci, F., Sardo, A. S., Tagliabue, G., Tisano, F., Usala, M., Vercelli, M., Vitale, F., Vitarelli, S., and Zambon, P.
109. [Cancer mortality in Southern Italy, 1999-2003]
- Author
-
Bidoli E, Montella M, Bruzzone S, De Paoli A, Fusco M, Frova L, Pace M, Pappagallo M, and Diego Serraino
110. Cancer mortality by urbanization and altitude in a limited area in Northeastern Italy
- Author
-
Bidoli E, Franceschi S, Luigino Dal Maso, Guarneri S, and Barbone F
- Subjects
Adult ,Male ,Rural Population ,Adolescent ,Urban Population ,Altitude ,Urbanization ,Infant, Newborn ,Infant ,Middle Aged ,Death Certificates ,Sex Factors ,Italy ,Residence Characteristics ,Risk Factors ,Child, Preschool ,Neoplasms ,Population Surveillance ,Confidence Intervals ,Humans ,Female ,Child ,Life Style ,Aged - Abstract
The geographical patterns of cancer mortality have been studied in Friuli-Venezia Giulia Region (1.2 million inhabitants), the North-eastern part of Italy, with respect to certain characteristics (i.e., rural, mixed, urban) and the altitude of the commune where the deceased subjects lived permanently at the time of death. In males, significantly increased mortality rates in rural versus urban communes (after allowance for altitude) were found for cancer of the oral cavity and pharynx, oesophagus and stomach. Conversely, significantly decreased mortality rates emerged for cancer of the colo-rectum, liver, lung, bladder, kidney and Hodgkin's disease. In females, significantly increased mortality rates in rural as compared to urban communes were observed for stomach cancer while significantly decreased mortality rates emerged for cancer of the colo-rectum, gallbladder, lung, breast, ovary, bladder and brain. With respect to altitude, residence above 200 meters retained a significant association in males, after allowance for the degree of urbanization of the commune of residence, for cancer of the oral cavity and pharynx, stomach and larynx (positive) and cancer of the colorectum and brain (negative). Women in locations above 200 meters seemed significantly at risk for stomach cancer, but protected from cancer of the colo-rectum and kidney. These results may provide a useful summary guide for further aetiological investigations into the risk factors associated with the diseases and give practical indications for local strategies of cancer control.
111. Sources of selected vitamins in a sample of the Italian population
- Author
-
Parpinel, M., Bidoli, E., Talamini, R., Luigino Dal Maso, and Franceschi, S.
112. Epidemiology of cancer in Friuli-Venezia Giulia
- Author
-
silvia franceschi and Bidoli, E.
113. [Time trends in infectious disease mortality in Italy: 1969-1999]
- Author
-
Diego Serraino, Bidoli E, Piselli P, Angeletti C, Bruzzone S, Pappagallo M, Puro V, Girardi E, Lauria F, Ippolito G, and Gruppo italiano studi mortalità malattie infettive
114. Uro-genital diseases and renal cell cancer in northern Italy
- Author
-
Talamini, R., La Vecchia, C., Negri, E., Bidoli, E., and silvia franceschi
115. Meal Frequency and Risk of Colorectal Cancer
- Author
-
Franceschi S, Carlo La Vecchia, Bidoli E, Negri E, and Talamini R
- Subjects
Adult ,Bile Acids and Salts ,Male ,Risk ,Humans ,Female ,Feeding Behavior ,Middle Aged ,Colorectal Neoplasms ,Aged - Abstract
The relation between meal frequency and the risk of colorectal cancer was investigated in a case-control study conducted in North Italy on 889 cases of colon cancer, 581 cases of rectal cancer, and 2475 controls admitted to hospital for acute, nonneoplastic, or digestive disorders. As compared to individuals who reported 2 or fewer meals per day, the multivariate colon cancer odds ratios were 1.7 [95% confidence interval (95% CI), 1.5-2.1] for 3, and 1.9 (95% CI, 1.1-3.3) for 4 meals or more. Corresponding rectal cancer odds ratios were 1.4 (95% CI, 1.1-1.7) for 3, and 1.9 (95% CI, 1.1-3.5) for 4 meals or more. The direct trends in risk of colorectal cancer with frequency of eating were not substantially modified by allowance for various dietary and nondietary potential confounding factors, including an approximate measure of total energy intake, and did not show significant effect modification across strata of age, sex, education, and other major risk covariates. A role of meal frequency in the etiology of colorectal cancer is biologically plausible, since when a meal is eaten, the gallbladder contracts and releases bile acids. Thus, eating patterns can influence the enterohepatic circulation and, consequently, the exposure time of intestinal mucosa to bile acids.
116. Micronutrients and ovarian cancer: an Italian case-control study
- Author
-
Bidoli, E., La Vecchia, C., Talamini, R., Negri, E., Maria Parpinel, Conti, E., Montella, M., Carbone, A., and Franceschi, S.
- Subjects
Adult ,Ovarian Neoplasms ,Minerals ,Incidence ,Feeding Behavior ,Vitamins ,Middle Aged ,Antioxidants ,Diet ,Calcium, Dietary ,Parity ,Italy ,Case-Control Studies ,Surveys and Questionnaires ,Confidence Intervals ,Odds Ratio ,Humans ,Regression Analysis ,Female ,Micronutrients ,Aged
117. Can we predict which patients are at risk of fluoropyrimidines cardiotoxicity?
- Author
-
Lestuzzi, C., Tartuferi, L., Viel, E., Virdone, S., Vaccher, E., Spazzapan, S., Paoli, A., Buonadonna, A., Arben Lleshi, and Bidoli, E.
118. Helicobacter pylori gastric niche in patients at increased gastric cancer risk
- Author
-
Zanussi, S., Basaglia, G., Paoli, P., Cannizzaro, R., Re, V., Pratesi, C., Scaini, C., Vincenzo Canzonieri, Bidoli, E., and Casarotto, M.
119. Adenocarcinoma of the stomach: univariate and multivariate analyses of factors associated with survival
- Author
-
Angela Buonadonna, Lombardi, D., Paoli, A., Bidoli, E., and Frustaci, S.
120. Habits and opinions about cigarette smoking among medical, nursing and technico-administrative staff at the Magenta Hospital (Local Health Unit no. 72) | Indagine sulle abitudini e le opinioni nei confronti del fumo di sigarette tra il personale medico, infermieristico e tecnico-amministrativo dell'Ospedale di Magenta (Usl 72)
- Author
-
Talamini, R., Bidoli, E., Serraino, D., Barra, S., silvia franceschi, and Bollini, P.
121. The epidemiology of non-Hodgkin's lymphoma in the north-east of Italy: A hospital-based case-control study
- Author
-
Franceschi, S., primary, Serraino, D., additional, Bidoli, E., additional, Talamini, R., additional, Tirelli, U., additional, Carbone, A., additional, and La Vecchia, C., additional
- Published
- 1989
- Full Text
- View/download PDF
122. Anthrax, Botulism and Tularemia in Italy.
- Author
-
Serraino, D., Puro, V., Bidoli, E., Piselli, P., Girardi, E., and Ippolito, G.
- Subjects
BACTERIAL diseases ,ANTHRAX - Abstract
A letter to the editor is presented commenting on the threat of anthrax, botulism and tularemia in Italy.
- Published
- 2003
- Full Text
- View/download PDF
123. Time trends of cancer mortality among elderly in Italy, 1970–2008: an observational study
- Author
-
Bidoli Ettore, Fratino Lucia, Bruzzone Silvia, Pappagallo Marilena, De Paoli Paolo, Tirelli Umberto, and Serraino Diego
- Subjects
Cancer mortality ,Time trends ,Elderly ,Italy ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background The aging of the Italian population will unavoidably lead to a growing number of persons diagnosed and living with cancer. A comprehensive description of the burden of cancer mortality among Italian elderly (65-84 years of age) in the last four decades has not been carried out yet. Cancer mortality rates were used to describe time trends between 1970-2008. Methods Mortality counts, provided by the Italian National Institute of Statistics, were grouped according to data availability: in quinquennia from 1970-74 through 1995-99, and in 2000-03 and 2006-08 groups. Age-standardized rates (world population) were computed by calendar periods while annual percent changes (APCs) were computed for elderly and middle aged (35-64 years) people for the period 1995-2008. Results The number of cancer deaths in elderly nearly doubled between 1970-74 (31,400 deaths/year in men, and 24,000 in women) and 2006-08 (63,000 deaths/year in men, and 42,000 in women). Overall cancer mortality rates peaked during the quinquennia 1985-89 and 1990-94 (about 1,500/100,000 in men and 680 in women) and declined thereafter. Throughout 1995-2008 cancer mortality rates decreased by -1.6%/year in men and -0.9%/year in women. These decreases were mainly driven by cancers of the stomach, bladder, prostate, and lung (APC = -3.3%, -2.7%, -2.5%, -2.2%, respectively) in men, and by cancers of the stomach, bladder, and breast (APC = -3.5%, -1.9%, -1.1%, respectively) in women. Conversely, increases in mortality rates between 1995 and 2008 were recorded for lung cancer (APC = +0.6%) in women, cutaneous melanoma (APC = +1.7%) in men, and pancreatic cancer (APC = +0.6% in men and +0.9% in women). Conclusions Overall favorable trends in cancer mortality were observed among Italian elderly between 1995 and 2008. Early diagnosis, improved efficacy of anti-cancer treatments and management of comorbidities are the most likely explanations of these positive observations. However, enduring preventive interventions against the most common risk factor (e.g. cigarette smoking), early diagnosis, and access to care should be reconsidered and extended to match the reductions of cancer mortality recorded in the elderly with those in the middle aged.
- Published
- 2012
- Full Text
- View/download PDF
124. Methylation levels of the 'long interspersed nucleotide element-1' repetitive sequences predict survival of melanoma patients
- Author
-
Colizzi Francesca, Parisi Giulia, Covre Alessia, Bidoli Ettore, Fratta Elisabetta, Sigalotti Luca, Coral Sandra, Massarut Samuele, Kirkwood John M, and Maio Michele
- Subjects
Medicine - Abstract
Abstract Background The prognosis of cutaneous melanoma (CM) differs for patients with identical clinico-pathological stage, and no molecular markers discriminating the prognosis of stage III individuals have been established. Genome-wide alterations in DNA methylation are a common event in cancer. This study aimed to define the prognostic value of genomic DNA methylation levels in stage III CM patients. Methods Overall level of genomic DNA methylation was measured using bisulfite pyrosequencing at three CpG sites (CpG1, CpG2, CpG3) of the Long Interspersed Nucleotide Element-1 (LINE-1) sequences in short-term CM cultures from 42 stage IIIC patients. The impact of LINE-1 methylation on overall survival (OS) was assessed using Cox regression and Kaplan-Meier analysis. Results Hypomethylation (i.e., methylation below median) at CpG2 and CpG3 sites significantly associated with improved prognosis of CM, CpG3 showing the strongest association. Patients with hypomethylated CpG3 had increased OS (P = 0.01, log-rank = 6.39) by Kaplan-Meyer analysis. Median OS of patients with hypomethylated or hypermethylated CpG3 were 31.9 and 11.5 months, respectively. The 5 year OS for patients with hypomethylated CpG3 was 48% compared to 7% for patients with hypermethylated sequences. Among the variables examined by Cox regression analysis, LINE-1 methylation at CpG2 and CpG3 was the only predictor of OS (Hazard Ratio = 2.63, for hypermethylated CpG3; 95% Confidence Interval: 1.21-5.69; P = 0.01). Conclusion LINE-1 methylation is identified as a molecular marker of prognosis for CM patients in stage IIIC. Evaluation of LINE-1 promises to represent a key tool for driving the most appropriate clinical management of stage III CM patients.
- Published
- 2011
- Full Text
- View/download PDF
125. Late tamoxifen in patients previously operated for breast cancer without postoperative tamoxifen: 5-year results of a single institution randomised study
- Author
-
Bidoli Ettore, Scalone Simona, Crivellari Diana, Magri Maria D, Miolo GianMaria, Veronesi Andrea, and Lombardi Davide
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background A population of breast cancer patients exists who, for various reasons, never received adjuvant post-operative tamoxifen (TAM). This study was aimed to evaluate the role of late TAM in these patients. Methods From 1997 to 2003, patients aged 35 to 75 years, operated more than 2 years previously for monolateral breast cancer without adjuvant TAM, with no signs of metastases and no contraindication to TAM were randomized to TAM 20 mg/day orally for 2 years or follow-up alone. Events were categorized as locoregional relapse, distant metastases, metachronous breast cancer, tumours other than breast cancer and death from any causes, whichever occurred first. The sample size (197 patients per arm, plus 10% allowance) was based on the assumption of a 30% decrease in the number of events occurring at a rate of 5% annually in the 10 years following randomization. Four hundred and thirty-three patients were randomized in the study (TAM 217, follow-up 216). Patients characteristics (TAM/follow-up) included: median age 55/55 years, median time from surgery 25/25 months (range, 25-288/25-294), in situ carcinoma 18/24, oestrogen receptor (ER) positive in 75/68, negative in 70/57, unknown in 72/91 patients. Previous adjuvant treatment included chemotherapy in 131/120 and an LHRH analogue in 11/13 patients. Results Thirty-six patients prematurely discontinued TAM after a median of 1 month, mostly because of subjective intolerance. Eighty-three events (TAM 39, follow-up 44) occurred: locoregional relapse in 10/8, distant metastases in 14/16, metachronous breast cancer in 4/10, other tumours in 11/10 patients. Less ER-positive secondary breast cancers occurred in the TAM treated patients than in follow-up patients (1 vs 10, p = 0.005). Event-free survival was similar in both groups of patients. Conclusions This 5-year analysis revealed significantly less metachronous ER-positive breast cancers in the TAM treated patients. No other statistically significant differences have emerged thus far.
- Published
- 2010
- Full Text
- View/download PDF
126. Phenotypic features and genetic characterization of male breast cancer families: identification of two recurrent BRCA2 mutations in north-east of Italy
- Author
-
Miolo GianMaria, Puppa Lara, Santarosa Manuela, De Giacomi Clelia, Veronesi Andrea, Bidoli Ettore, Tibiletti Maria, Viel Alessandra, and Dolcetti Riccardo
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Breast cancer in men is an infrequent occurrence, accounting for ~1% of all breast tumors with an incidence of about 1:100,000. The relative rarity of male breast cancer (MBC) limits our understanding of the epidemiologic, genetic and clinical features of this tumor. Methods From 1997 to 2003, 10 MBC patients were referred to our Institute for genetic counselling and BRCA1/2 testing. Here we report on the genetic and phenotypic characterization of 10 families with MBC from the North East of Italy. In particular, we wished to assess the occurrence of specific cancer types in relatives of MBC probands in families with and without BRCA2 predisposing mutations. Moreover, families with recurrent BRCA2 mutations were also characterized by haplotype analysis using 5 BRCA2-linked dinucleotide repeat markers and 8 intragenic BRCA2 polymorphisms. Results Two pathogenic mutations in the BRCA2 gene were observed: the 9106C>T (Q2960X) and the IVS16-2A>G (splicing) mutations, each in 2 cases. A BRCA1 mutation of uncertain significance 4590C>G (P1491A) was also observed. In families with BRCA2 mutations, female breast cancer was more frequent in the first and second-degree relatives compared to the families with wild type BRCA1/2 (31.9% vs. 8.0% p = 0.001). Reconstruction of the chromosome phasing in three families and the analysis of three isolated cases with the IVS16-2A>G BRCA2 mutation identified the same haplotype associated with MBC, supporting the possibility that this founder mutation previously detected in Slovenian families is also present in the North East of our Country. Moreover, analysis of one family with the 9106C>T BRCA2 mutation allowed the identification of common haplotypes for both microsatellite and intragenic polymorphisms segregating with the mutation. Three isolated cases with the same mutation shared the same intragenic polymorphisms and three 5' microsatellite markers, but showed a different haplotype for 3' markers, which were common to all three cases. Conclusion The 9106C>T and the IVS16-2A>G mutations constitute recurrent BRCA2 mutations in MBC cases from the North-East of Italy and may be associated with a founder effect. Knowledge of these two recurrent BRCA2 mutations predisposing to MBC may facilitate the analyses aimed at the identification of mutation carriers in our geographic area.
- Published
- 2006
- Full Text
- View/download PDF
127. Familial breast cancer: characteristics and outcome of BRCA 1–2 positive and negative cases
- Author
-
Viel Alessandra, Dolcetti Riccardo, Scuderi Cristina, Zanetti Martina, Lombardi Davide, Magri Maria D, Giacomi Clelia de, Veronesi Andrea, Crivellari Diana, Bidoli Ettore, and Boiocchi Mauro
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background The clinical and pathological characteristics and the clinical course of patients with breast cancer and BRCA 1–2 mutation are poorly known. Methods From 1997, patients with breast cancer and a family history of breast or ovarian cancer were offered BRCA testing. The clinical and pathological features of patients with known BRCA status were retrospectively assessed and comparisons were made between cancers arising in BRCA positive and BRCA wild type (WT) patients respectively. Type of treatment, pattern of relapse, event (local relapse, contralateral breast cancer, metastases) free and overall survival were also compared in the two groups. Out of the 210 patients tested, 125 had been treated and followed-up at our Institution and were evaluated in this study. Results BRCA positive patients tended to be more often premenopausal (79% vs 65%) and to have positive lymphnodes (63% vs 49%), poorly differentiated tumours (76% vs 40% – p = 0.002 at univariate analysis, not significant at multivariate analysis) and negative estrogen receptors (43% vs 29%). Treatment was not different in the two groups. In the 86 BRCA-WT patients, the first event was a local relapse in 3 (3%), metachronous contralateral breast cancer in 7 (8%) and distant metastases in 16 (19%). In the 39 BRCA positive patients, the corresponding figures were 3 (8%), 8 (21%) and 3 (8%). There was no difference in event free survival, with a median of 180 months in both groups of patients. At 20 years, projected survival was 85% for BRCA positive patients and 55% for BRCA-WT, but this difference was not statistically significant. Conclusion Although BRCA positive patients have more frequently negative prognostic factors, their prognosis appears to be equal to or better than in patients with BRCA-WT.
- Published
- 2005
- Full Text
- View/download PDF
128. Efficacy of colonoscopy and endoscopic polypectomy in colorectal cancer prevention: A cohort study
- Author
-
Formasarig, M., Veronesi, A., Bidoli, E., Paolello, C., Cannizzaro, R., Spazzapan, S., Vram, A., Frezza, M., Benedetti, G., Sablich, R., and Benedetti, E.
- Published
- 2001
- Full Text
- View/download PDF
129. Reirradiation and lomustine in patients with relapsed high grade gliomas
- Author
-
Bortolus, R., Arcicasa, M., Roncadin, M., Bidoli, E., Dedkov, A., Gigante, M., and Trovo, M.G.
- Published
- 1998
- Full Text
- View/download PDF
130. Metabolic syndrome is associated with colorectal cancer in men.
- Author
-
Pelucchi C, Negri E, Talamini R, Levi F, Giacosa A, Crispo A, Bidoli E, Montella M, Franceschi S, and La Vecchia C
- Abstract
AIM OF THE STUDY: We assessed the relation between metabolic syndrome (MetS) and its components and colorectal cancer. METHODS: We analysed data from a multicentre case-control study conducted in Italy and Switzerland, including 1378 cases of colon cancer, 878 cases of rectal cancer and 4661 controls. All cases were incident and histologically confirmed. Controls were subjects admitted to the same hospitals as cases with acute non-malignant conditions. MetS was defined according to the International Diabetes Federation criteria. Odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were estimated by multiple logistic regression models, including terms for major identified confounding factors for colorectal cancer. RESULTS: With reference to each component of the MetS, the ORs of colorectal cancer in men were 1.27 (95% CI, 0.95-1.69) for diabetes, 1.24 (95% CI, 1.03-1.48) for hypertension, 1.14 (95% CI, 0.93-1.40) for hypercholesterolaemia and 1.26 (95% CI, 1.08-1.48) for overweight at age 30. The corresponding ORs in women were 1.20 (95% CI, 0.82-1.75), 0.87 (95% CI, 0.71-1.06), 0.83 (95% CI, 0.66-1.03) and 1.06 (95% CI, 0.86-1.30). Colorectal cancer risk was increased in men (OR=1.86; 95% CI, 1.21-2.86), but not in women (OR=1.13; 95% CI, 0.66-1.93), with MetS. The ORs were 2.09 (95% CI, 1.38-3.18) in men and 1.15 (95% CI, 0.68-1.94) in women with > or =3 components of the MetS, as compared to no component. Results were similar for colon and rectal cancers. CONCLUSION: This study supports a direct association between MetS and both colon and rectal cancers in men, but not in women. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
131. Fiber intake and pancreatic cancer risk: a case–control study
- Author
-
Jerry Polesel, Ettore Bidoli, Maurizio Montella, C. La Vecchia, Silvia Franceschi, R. Talamini, Diego Serraino, Giovanni Boz, A. Zucchetto, L. Dal Maso, Claudio Pelucchi, Eva Negri, Bidoli E, Pelucchi C, Zucchetto A, Negri E, Dal Maso L, Polesel J, Boz G, Montella M, Franceschi S, Serraino D, La Vecchia C, Talamini R, E. Bidoli, C. Pelucchi, A. Zucchetto, E. Negri, L. Dal Maso, J. Polesel, G. Boz, M. Montella, S. Franceschi, D. Serraino, C. La Vecchia, and R. Talamini
- Subjects
Adult ,Dietary Fiber ,Male ,medicine.medical_specialty ,Neuroendocrine tumors ,Gastroenterology ,Risk Factors ,Internal medicine ,Pancreatic cancer ,Odds Ratio ,medicine ,Humans ,Fiber ,Food science ,Aged ,Aged, 80 and over ,business.industry ,Confounding ,Case-control study ,Hematology ,Odds ratio ,Middle Aged ,medicine.disease ,Confidence interval ,Diet ,Pancreatic Neoplasms ,Oncology ,Case-Control Studies ,Etiology ,Female ,business - Abstract
Background Scanty and inconsistent studies are available on the relation between dietary fiber intake and pancreatic cancer. A case–control study was carried out in northern Italy to further investigate the role of various types of dietary fibers in the etiology of pancreatic cancer. Patients and methods Cases were 326 patients with incident pancreatic cancer, excluding neuroendocrine tumors, admitted to major teaching and general hospitals during 1991–2008. Controls were 652 patients admitted for acute, nonneoplastic conditions to the same hospital network of cases. Information was elicited using a validated food frequency questionnaire. Odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were estimated for intake quintiles of different types of fiber after allowance for total energy intake and other potential confounding factors. Results Total fiber intake was inversely related to risk of pancreatic cancer (OR = 0.4 for highest versus lowest quintile of intake; 95% CI 0.2–0.7). An inverse association emerged between pancreatic cancer and both soluble (OR = 0.4; 95% CI 0.2–0.7) and total insoluble fiber (OR = 0.5; 95% CI 0.3–0.8), particularly cellulose (OR = 0.4; 95% CI 0.3–0.7) and lignin (OR = 0.5; 95% CI 0.3–0.9). Fruit fiber intake was inversely associated with pancreatic cancer (OR = 0.5; 95% CI 0.3–0.8), whereas grain fiber was not (OR = 1.2; 95% CI 0.7–2.0). Conclusions This study suggests that selected types of fiber and total fiber are inversely related to pancreatic cancer.
- Published
- 2012
132. Metabolic syndrome is associated with colorectal cancer in men
- Author
-
Silvia Franceschi, Renato Talamini, Claudio Pelucchi, Carlo La Vecchia, Maurizio Montella, Fabio Levi, Ettore Bidoli, Eva Negri, Attilio Giacosa, Anna Crispo, Pelucchi C, Negri E, Talamini R, Levi F, Giacosa A, Crispo A, Bidoli E, Montella M, Franceschi S, and La Vecchia C
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Colorectal cancer ,Overweight ,Risk Factors ,Internal medicine ,Diabetes mellitus ,Epidemiology ,medicine ,Humans ,Risk factor ,Aged ,Metabolic Syndrome ,Rectal Neoplasms ,business.industry ,Case-control study ,Cancer ,Middle Aged ,medicine.disease ,Endocrinology ,Oncology ,Case-Control Studies ,Colonic Neoplasms ,Female ,medicine.symptom ,Metabolic syndrome ,business - Abstract
Aim of the study: We assessed the relation between metabolic syndrome (MetS) and its components and colorectal cancer. Methods: We analysed data from a multicentre case-control study conducted in Italy and Switzerland, including 1378 cases of colon cancer, 878 cases of rectal cancer and 4661 controls. All cases were incident and histologically confirmed. Controls were subjects admitted to the same hospitals as cases with acute non-malignant conditions. MetS was defined according to the International Diabetes Federation criteria. Odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were estimated by multiple logistic regression models, including terms for major identified confounding factors for colorectal cancer. Results: With reference to each component of the MetS, the ORs of colorectal cancer in men were 1.27 (95% CI, 0.95-1.69) for diabetes, 1.24 (95% CI, 1.03-1.48) for hypertension, 1.14 (95% CI, 0.93-1.40) for hypercholesterolaemia and 1.26 (95% CI, 1.08-1.48) for overweight at age 30. The corresponding ORs in women were 1.20 (95% CI, 0.82-1.75), 0.87 (95% CI, 0.71-1.06), 0.83 (95% CI, 0.66-1.03) and 1.06 (95% CI, 0.86-1.30). Colorectal cancer risk was increased in men (OR = 1.86; 95% CI, 1.21-2.86), but not in women (OR = 1.13; 95% CI, 0.66-1.93), with MetS. The ORs were 2.09 (95% CI, 1.38-3.18) in men and 1.15 (95% CI, 0.68-1.94) in women with >= 3 components of the MetS, as compared to no component. Results were similar for colon and rectal cancers. Conclusion: This study supports a direct association between MetS and both colon and rectal cancers in men, but not in women. (C) 2010 Elsevier Ltd. All rights reserved.
- Published
- 2010
133. Nutrient-based dietary patterns and nasopharyngeal cancer: Evidence from an exploratory factor analysis
- Author
-
Valeria Edefonti, Francesca Bravi, Adriano Decarli, Werner Garavello, Ettore Bidoli, Cristina Bosetti, Monica Ferraroni, Diego Serraino, C. La Vecchia, Jerry Polesel, Stefano Calza, Federica Nicolussi, Edefonti, V, Nicolussi, F, Polesel, J, Bravi, F, Bosetti, C, Garavello, W, La Vecchia, C, Bidoli, E, Decarli, A, Serraino, D, Calza, S, and Ferraroni, M
- Subjects
Adult ,Dietary Fiber ,Male ,Pathology ,medicine.medical_specialty ,Cancer Research ,Adolescent ,dietary patterns ,Nasopharyngeal neoplasm ,nasopharyngeal cancer ,factor analysis ,Physiology ,Vegetable ,Logistic regression ,Settore MED/01 - STATISTICA MEDICA ,Young Adult ,nutrients ,Vegetables ,Humans ,Medicine ,Young adult ,Aged ,Animal fat ,Nasopharyngeal Neoplasm ,business.industry ,nutrient ,Case-control study ,Cancer ,Nasopharyngeal Neoplasms ,Nutrition Survey ,Odds ratio ,Feeding Behavior ,Middle Aged ,Nutrition Surveys ,medicine.disease ,Diet ,Quartile ,factor analysi ,Italy ,Oncology ,Case-Control Studies ,Clinical Study ,Carcinoma, Squamous Cell ,Female ,dietary pattern ,business ,Case-Control Studie ,Human - Abstract
Background: The issue of diet and laryngeal cancer has been rarely addressed considering the potential role of dietary patterns. Methods: We examined this association using data from a case-control study carried out between 1992 and 2000. Cases were 460 histologically confirmed incident laryngeal cancers hospitalized in two Italian areas. Controls were 1,088 subjects hospitalized for acute nonneoplastic diseases unrelated to tobacco or alcohol consumption. Dietary habits were investigated through a 78-item food frequency questionnaire. A posteriori dietary patterns were identified through principal component factor analysis carried out on a selected set of 28 major nutrients. The internal reproducibility, robustness, and reliability of the identified patterns were evaluated. Odds ratios (OR) of laryngeal cancer and 95% confidence intervals (95% CI) were estimated using unconditional multiple logistic regression models on quartiles of factor scores. Results: We identified five major dietary patterns named “animal products, ”“ starch-rich, ”“ vitamins and fiber, ”“ vegetable unsaturated fatty acids,” and “animal unsaturated fatty acids.” The vitamins and fiber dietary pattern was inversely associated with laryngeal cancer (OR, 0.35; 95% CI, 0.24-0.52 for the highest versus the lowest score quartile), whereas the animal products (OR, 2.34; 95% CI, 1.59-3.45) and the animal unsaturated fatty acids (OR, 2.07; 95% CI, 1.42-3.01) patterns were directly associated with it. There was no significant association between the vegetable unsaturated fatty acids and the starch-rich patterns and laryngeal cancer risk. Conclusion: These findings suggest that diets rich in animal products and animal fats are directly related, and those rich in fruit and vegetables inversely related, to laryngeal cancer risk. Cancer Epidemiol Biomarkers
- Published
- 2015
134. Micronutrients and ovarian cancer: A case-control study in Italy
- Author
-
E. Conti, E. Negri, C. La Vecchia, Ettore Bidoli, Silvia Franceschi, Maria Parpinel, R. Talamini, Maurizio Montella, Alessia Carbone, Bidoli E, La Vecchia C, Talamini R, Negri E, Parpinel M, Conti E, Montella M, Carbone A, and Franceschi S
- Subjects
Adult ,Vitamin ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Physiology ,Xanthophylls ,Food group ,Eating ,chemistry.chemical_compound ,Breast cancer ,Risk Factors ,Zeaxanthins ,Surveys and Questionnaires ,Internal medicine ,Odds Ratio ,Humans ,Vitamin E ,Medicine ,Micronutrients ,Aged ,Ovarian Neoplasms ,business.industry ,Incidence ,Lutein ,Case-control study ,Cancer ,Feeding Behavior ,Hematology ,Odds ratio ,Middle Aged ,beta Carotene ,Micronutrient ,medicine.disease ,Endocrinology ,Italy ,Oncology ,chemistry ,Case-Control Studies ,Calcium ,Female ,business - Abstract
Background: The role of selected micronutrients, vitamins and minerals in the aetiology of epithelial ovarian cancer was investigated using data from a case-control study conducted between 1992 and 1999 in five Italian areas. Patients and methods:Cases were 1031 patients with histologically confirmed incident epithelial ovarian cancer. Controls were 2411 subjects admitted for acute, non-neoplastic diseases to major hospitals in the same catchment areas. Dietary habits were elicited using a validated food frequency questionnaire including 78 food groups and recipes. Odds ratios (OR) and 95% confidence intervals (95% CI) were computed by quintiles of intake of nutrients. Results: Inverse associations emerged for vitamin E (OR = 0.6; 95% CI: 0.5-0.8), beta-carotene (OR = 0.8; 95% CI: 0.6-1.0), lutein/zeaxanthin (OR = 0.6; 95% CI: 0.5-0.8 for the highest vs. the lowest quintile of intake), and calcium intake (OR = 0.7; 95% CI: 0.6-1.0). When the combined effect of calcium and vitamin E was considered, the OR reached 0.4 (95% CI: 0.3-0.7) for subjects in the highest compared to those in the lowest intake tertile of both micronutrients. Results were consistent across strata of menopausal status, parity and family history of ovarian or breast cancer. Conclusions: The intake of selected micronutrients, which were positively correlated to a diet rich in vegetables and fruits, was inversely associated with ovarian cancer. RI Parpinel, Maria/B-1605-2012
- Published
- 2001
135. Fiber intake and endometrial cancer risk
- Author
-
Renato Talamini, Diego Serraino, Ettore Bidoli, Antonella Zucchetto, Carlo La Vecchia, Silvia Franceschi, Jerry Polesel, Claudio Pelucchi, Eva Negri, Luigino Dal Maso, Maurizio Montella, E. Bidoli, C. Pelucchi, A. Zucchetto, E. Negri, L. Dal Maso, J. Polesel, M. Montella, S. Franceschi, D. Serraino, C. La Vecchia, R. Talamini, Bidoli E, Pelucchi C, Zucchetto A, Negri E, Dal Maso L, Polesel J, Montella M, Franceschi S, Serraino D, La Vecchia C, and Talamini R
- Subjects
Adult ,Dietary Fiber ,Oncology ,medicine.medical_specialty ,Food Handling ,Biological Availability ,Lignin ,Risk Assessment ,Fiber intake ,Risk Factors ,Surveys and Questionnaires ,Internal medicine ,Vegetables ,Epidemiology ,Odds Ratio ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Aged ,Gynecology ,business.industry ,Endometrial cancer ,Estrogen Replacement Therapy ,Confounding ,Case-control study ,Confounding Factors, Epidemiologic ,Feeding Behavior ,Hematology ,General Medicine ,Odds ratio ,Middle Aged ,medicine.disease ,Endometrial Neoplasms ,Menopause ,Italy ,Case-Control Studies ,Fruit ,Sample Size ,Female ,Edible Grain ,Risk assessment ,business - Abstract
Background. The epidemiological evidence on the relation between dietary fiber intake and endometrial cancer is contradictory. Consequently, a case-control study was carried out to further investigate the role of dietary fiber intake in the etiology of endometrial cancer. Material and methods. Cases were 454 women with incident, histologically confirmed, endometrial cancer admitted to major teaching and general hospitals. Controls were 908 women admitted for acute, non-neoplastic conditions to the same hospital network. Information on diet was elicited using a validated food frequency questionnaire. Results. Odds ratios (OR) and 95% confidence intervals (CI) for quintiles of various types of fiber were estimated after allowance for total energy intake and other potential confounding factors. Lignin intake was significantly inversely related to endometrial cancer (OR=0.6 for the highest versus the lowest quintile of intake; 95%CI: 0.4-0.9) with a slightly significant linear trend in risk (p-value=0.04). Discussion. Data suggest the potential importance of lignin in the prevention of endometrial cancer at Italian consumption levels.
- Published
- 2010
136. Dietary vitamins E and C and prostate cancer risk
- Author
-
Oliviero Lenardon, Luigino Dal Maso, Renato Talamini, Maurizio Montella, Diego Serraino, Ettore Bidoli, Eva Negri, Silvia Franceschi, Carlo La Vecchia, Cristina Bosetti, Jerry Polesel, Antonella Zucchetto, E. Bidoli, R. Talamini, A. Zucchetto, C. Bosetti, E. Negri, O. Lenardon, L. Dal Maso, J. Polesel, M. Montella, S. Franceschi, D. Serraino, C. La Vecchia, Bidoli E, Talamini R, Zucchetto A, Bosetti C, Negri E, Lenardon O, Dal Maso L, Polesel J, Montella M, Franceschi S, Serraino D, and La Vecchia C
- Subjects
Oncology ,Male ,medicine.medical_specialty ,MEDLINE ,Ascorbic Acid ,Antioxidants ,Prostate cancer ,Risk Factors ,Internal medicine ,Medicine ,Humans ,Vitamin E ,Radiology, Nuclear Medicine and imaging ,Aged ,Prostate cancer risk ,Gynecology ,business.industry ,Dietary intake ,Incidence (epidemiology) ,Incidence ,Case-control study ,Prostatic Neoplasms ,Hematology ,General Medicine ,Middle Aged ,medicine.disease ,Diet ,Multicenter study ,Italy ,Case-Control Studies ,business - Abstract
Background. The epidemiologic evidence on dietary vitamins E and C and prostate cancer is controversial. Therefore, a case-control study was carried out to investigate the role of dietary intake of vitamins E and C in the etiology of prostate cancer. Material and methods. Cases were 1 294 men with incident, histologically confirmed prostate cancer, admitted to the major teaching and general hospitals of five Italian areas between 1991 and 2002. Controls were 1 451 men admitted for acute, non-neoplastic conditions to the same hospitals. Information on dietary habits and nutrient intake was elicited using a validated food frequency questionnaire including 78 food groups and recipes. Odds ratios (OR) and 95% confidence intervals (CI) for increasing levels of vitamin intake were estimated after allowance for total energy intake and other confounding factors. Results. Vitamin E showed a significant inverse association with prostate cancer (OR = 0.78 for the highest versus the lowest tertile of intake, 95% CI: 0.58-0.96; p-value for trend = 0.02), whereas for vitamin C the inverse association was of borderline statistical significance (OR = 0.86; 95% CI: 0.65-1.08). Results were consistent in strata of age, body mass index, and family history of prostate cancer. Discussion. The present study shows an inverse association between dietary intake of vitamins E and prostate cancer incidence. This finding is likely to reflect the influence of diet itself since supplementation or food fortification with vitamins is rare in the Italian population.
- Published
- 2009
137. Macronutrients, fatty acids, cholesterol and renal cell cancer risk
- Author
-
Cristina Bosetti, Silvia Franceschi, Ettore Bidoli, Renato Talamini, Jerry Polesel, Antonella Zucchetto, Daniele Maruzzi, Maurizio Montella, Eva Negri, Carlo La Vecchia, Bidoli E, Talamini R, Zucchetto A, Polesel J, Bosetti C, Negri E, Maruzzi D, Montella M, Franceschi S, La Vecchia C, E. Bidoli, R. Talamini, A. Zucchetto, J. Polesel, C. Bosetti, E. Negri, D. Maruzzi, M. Montella, S. Franceschi, and C. La Vecchia
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Linolenic acid ,Linoleic acid ,Macronutrient ,Physiology ,Risk Assessment ,Food group ,Fatty Acids, Monounsaturated ,chemistry.chemical_compound ,Risk Factors ,Internal medicine ,Surveys and Questionnaires ,medicine ,Confidence Intervals ,Odds Ratio ,Humans ,Risk factor ,Carcinoma, Renal Cell ,Aged ,Renal cell cancer ,chemistry.chemical_classification ,Cholesterol ,business.industry ,Fatty Acids ,Case-control study ,Confounding Factors, Epidemiologic ,Starch ,Odds ratio ,Middle Aged ,Dietary Fats ,Kidney Neoplasms ,Diet ,Endocrinology ,Oncology ,chemistry ,Italy ,Case-Control Studies ,Fatty Acids, Unsaturated ,Female ,business ,Body mass index ,Polyunsaturated fatty acid - Abstract
The role of selected macronutrients, fatty acids and cholesterol in the etiology of renal cell carcinoma (RCC) was analyzed using data from a case-control study conducted in 4 Italian areas between 1992 and 2004. Cases were 767 patients with incident, histologically confirmed RCC, admitted to major teaching and general hospitals of the study areas. Controls were 1,534 subjects admitted for acute, nonneoplastic conditions to the same hospitals. Information on dietary habits and nutrient intake was elicited using a validated food frequency questionnaire including 78 food groups and recipes. Odds ratios (OR) and 95% confidence intervals (CI) for increasing levels of nutrient intake were estimated after allowance for total energy intake and other potential confounding factors. A direct association with RCC was found for starch intake (OR = 1.9 for highest versus lowest quintile of intake; 95% Cl: 1.4-2.6, p-value for trend = 0.001), while an inverse association was found for fats from vegetable sources (OR = 0.6; 95% CI: 0.5-0.8; p-value for trend = 0.002), unsaturated fatty acids (OR = 0.5; 95% Cl: 0.4-0.7; p-value for trend = 0.0002), and polyunsaturated fatty acids (OR = 0.5; 95% Cl: 0.40.7; p-value for trend = 0.001). Among polyunsaturated fatty acids, linoleic acid (OR = 0.5; 95% CI: 0.4-0.7; p-value for trend = 0.0001) and linolenic acid (OR = 0.7; 95% CI: 0.5-1.0; p-value for trend = 0.01) were inversely related to RCC. When 6 major macronutrients were included in the same model, the adverse effect of high intake of starch remained statistically significant, together with the protective effect of polyunsaturated fatty acids. Results were consistent in strata of age, body mass index, treated hypertension, energy intake, stage and family history of RCC. (C) 2008 Wiley-Liss, Inc.
- Published
- 2008
138. Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type
- Author
-
Ettore Bidoli, Stefania Zanussi, Maria Teresa Bortolin, Chiara Pratesi, Emanuela Vaccher, Riccardo Dolcetti, Rosamaria Tedeschi, Paolo De Paoli, Massimo Guidoboni, Luigi Barzan, Calogero Caruso, Gianni Franchin, PRATESI C, BORTOLIN MT, BIDOLI E, TEDESCHI R, VACCHER E, DOLCETTI R, GUIDOBONI M, FRANCHIN G, BARZAN L, ZANUSSI S, CARUSO C, and DE PAOLI P
- Subjects
Male ,Cancer Research ,Epstein-Barr Virus Infections ,Genotype ,Immunology ,Nasopharyngeal neoplasm ,Single-nucleotide polymorphism ,Biology ,Polymerase Chain Reaction ,Polymorphism, Single Nucleotide ,Cohort Studies ,Interleukin-10, Interleukin-18, Single nucleotide polymorphisms (SNPs), Undifferentiated carcinoma of nasopharyngeal type (UCNT), Epstein Barr virus (EBV) ,Risk Factors ,Genetic predisposition ,Immunology and Allergy ,Humans ,Genetic Predisposition to Disease ,Genetic variability ,Allele ,Promoter Regions, Genetic ,Allele frequency ,Inflammation ,Carcinoma ,Interleukin-8 ,Case-control study ,Nasopharyngeal Neoplasms ,Middle Aged ,Prognosis ,Interleukin-10 ,Oncology ,Italy ,Case-Control Studies ,Female - Abstract
Purpose: Cytokines such as IL-10 and IL-18 seem to be involved in the inflammatory response of undifferentiated carcinoma of nasopharyngeal type (UCNT). The aim of this study was to evaluate the correlation between functional single nucleotide polymorphisms (SNPs) in the promoter region of IL-10 and IL-18 genes and the virological and clinical characteristics in a large case series of Caucasian patients suffering from UCNT, a tumor regularly associated with the Epstein Barr Virus (EBV). Methods: Eighty-nine patients with histologically confirmed UCNT and 130 healthy donors were included in our study. DNA was examined for the polymorphisms of IL-10 gene at positions –1082, −819, −592 by direct sequencing and IL-18 gene at position −607 and −137 by allele –specific PCR. EBV DNA serum viremia was evaluated by QC-PCR. Results: The distributions of the IL-10 and IL-18 genetic variants were not different between UCNT patients and healthy controls. The frequency of IL-10 –1082G allele, which is associated with high IL-10 expression, showed a nearly statistically significant increase in UCNT patients EBV DNA-negative as compared to healthy controls (OR=3.3 95% CI: 1.2–9.8). Subjects with C/C or C/G combined IL-18 genotypes showed an increased risk of being with Stages III-IV (OR=2.1 95% CI: 1.2–6.6). Conclusion: This study was performed to improve the definition of the pathogenetic factors implicated in UCNT by addressing the correlation between cytokine polymorphisms and clinical parameters. This is the first study investigating the possible role of the IL-18 and IL-10 polymorphisms in the development and outcome of UCNT. In our genetic analysis there is no evidence for involvement of IL-10 promoter polymorphisms alone in the genetic predisposition to this tumor. On the other hand, IL18 genetic variants may represent a genetic risk factor for tumor aggressiveness.
- Published
- 2006
139. Macronutrients, fatty acids, cholesterol and prostate cancer risk
- Author
-
Silvia Franceschi, R. Talamini, Ettore Bidoli, Maurizio Montella, Cristina Bosetti, C. La Vecchia, D. Maruzzi, Eva Negri, Bidoli E, Talamini R, Bosetti C, Negri E, Maruzzi D, Montella M, Franceschi S, and La Vecchia C
- Subjects
Male ,medicine.medical_specialty ,Linolenic acid ,Linoleic acid ,Physiology ,Nutritional Status ,Food group ,Prostate cancer ,chemistry.chemical_compound ,Risk Factors ,Internal medicine ,medicine ,Humans ,Aged ,chemistry.chemical_classification ,Cholesterol ,business.industry ,Fatty Acids ,Prostatic Neoplasms ,Hematology ,Odds ratio ,Middle Aged ,medicine.disease ,Dietary Fats ,Endocrinology ,Oncology ,chemistry ,Case-Control Studies ,business ,Body mass index ,Polyunsaturated fatty acid - Abstract
Background: The role of selected macronutrients, fatty acids and cholesterol in the etiology of prostate cancer was analyzed using data from a case-control study carried out in five Italian areas between 1991 and 2002. Patients and methods: Cases were 1294 men with incident, histologically confirmed prostate cancer, and admitted to the major teaching and general hospitals of study areas. Controls were 1451 men admitted for acute, non-neoplastic conditions to the same hospital network. Information on dietary habits was elicited using a validated food frequency questionnaire including 78 food groups and recipes. Odds ratios (OR) and 95% confidence intervals (CI) were estimated for increasing levels of nutrient intake. Results: A direct association with prostate cancer was found for starch intake (OR = 1.4 in the highest versus the lowest quintile of intake; 95% CI: 1.1-1.8), whereas an inverse association emerged for polyunsaturated fatty acids (OR = 0.8; 95% CI: 0.6-1.0). Among polyunsaturated fatty acids, linolenic acid (OR = 0.7; 95% CI: 0.6-0.9) and linoleic acid (OR = 0.8; 95% CI: 0.6-1.0) were inversely related to prostate cancer. When the six major macronutrients were included in the same model, the adverse effect of high intake of starch and monounsaturated fatty acids was statistically significant together with the protective effect of polyunsaturated fatty acids. Results were consistent in separate strata of age, body mass index and family history of prostate cancer. Conclusions: Starch and monounsaturated fatty acids were directly associated with prostate cancer risk and polyunsaturated fatty acids were inversely associated.
- Published
- 2004
140. Immunohistochemical evaluation of multiple biological markers in ductal carcinoma in situ of the breast
- Author
-
Tiziana Perin, Ettore Bidoli, Anna Carbone, Mario Roncadin, Vincenzo Canzonieri, Samuele Massarut, Carlo Riccardo Rossi, Perin, T, Canzonieri, V, Massarut, S, Bidoli, E, Rossi, C, Roncadin, M, and Carbone, A
- Subjects
Adult ,Cancer Research ,Pathology ,medicine.medical_specialty ,Receptor expression ,Mammary gland ,Breast Neoplasms ,Biology ,Immunoenzyme Techniques ,Carcinoma ,medicine ,Biomarkers, Tumor ,Humans ,skin and connective tissue diseases ,Aged ,Aged, 80 and over ,Oncogene ,Carcinoma in situ ,Carcinoma, Ductal, Breast ,Ductal carcinoma ,Middle Aged ,medicine.disease ,Prognosis ,Neoplasm Proteins ,medicine.anatomical_structure ,Oncology ,Immunohistochemistry ,Histopathology ,Female ,Carcinoma in Situ - Abstract
In order to obtain prognostic clinicopathological information, 49 cases of pure ductal carcinoma in situ of the breast (DCIS), were evaluated for the immunohistochemical expression of potential predictor markers including c-erbB-2 oncogene product, p53 protein, oestrogen (ER) and progesterone (PR) receptors, oestrogen-regulated proteins pS2 and cathepsin-D (cath-D), CD44 protein and 67-kDa laminin receptor (MLuC5). Immunohistochemical findings were compared with conventional pathological parameters, clinical findings, and the clinical outcome of the patients. When markers were matched to each other, statistical analyses provided a significant positive correlation between c-erbB-2 overexpression and p53 positivity (P < 0.01) and between ER and PR (P < 0.01), ER, PR and pS2 (P < 0.01), pS2 and MLuC5 (P < 0.05). Significant negative correlations between c-erbB-2 overexpression and ER (P < 0.05), PR (P < 0.01) and pS2 (P < 0.01) positivity was also observed. Data on the relationship between marker status and pathological findings revealed a significant positive trend between c-erbB-2, p53, and increased grade values (P < 0.05) and opposite results with SR receptor expression (P < 0.01). c-erbB-2 overexpression was further significantly associated with comedotype carcinoma (P < 0.05) and distribution of disease in confluent neoplastic ducts (P < 0.01). Although no statistically significant correlation among biological markers expression, clinical findings and outcome was demonstrated, overall this study indicates that tumour cells from a subset of DCIS, which includes comedotype carcinoma, express significantly unfavourable prognostic factors. Copyright (C) 1996 Elsevier Science Ltd
- Published
- 1996
141. TOMATOES AND RISK OF DIGESTIVE-TRACT CANCERS
- Author
-
R. Talamini, Silvia Franceschi, Barbara D'Avanzo, Ettore Bidoli, Eva Negri, C. La Vecchia, FRANCESCHI S, BIDOLI E, LAVECCHIA C, TALAMINI R, DAVANZO B, and NEGRI E
- Subjects
Male ,Cancer Research ,Mediterranean diet ,Population ,Physiology ,Digestive System Neoplasms ,Solanum lycopersicum ,Risk Factors ,medicine ,Humans ,Food science ,education ,Aged ,education.field_of_study ,business.industry ,Stomach ,Case-control study ,Cancer ,Odds ratio ,Middle Aged ,medicine.disease ,Micronutrient ,medicine.anatomical_structure ,Italy ,Oncology ,Quartile ,Case-Control Studies ,Female ,business - Abstract
In view of the persisting uncertainty concerning possible mechanisms by which high vegetable and fruit intake decreases cancer risk, foods with divergent values for potentially important micronutrients are a priority for investigation. Tomatoes are low in beta-carotene, but high in lycopene, an active antioxidative agent. In order to assess the effect of tomatoes on risk of cancers of the digestive tract, data were analyzed from an integrated series of case-control studies conducted between 1985 and 1991 in northern Italy, where tomato intake is high but, also, heterogeneous. The overall dataset included the following histologically confirmed cancer cases: oral cavity and pharynx, 314; esophagus, 85; stomach, 723; colon, 955; and rectum, 629; and a total of 2,879 controls admitted to hospital for acute non-neoplastic or non-digestive conditions, unrelated to long-term dietary modifications. Multivariate odds ratios (OR) and 95% confidence interval (CI) for subsequent quartiles of intake of raw tomatoes were derived, after allowance for age, sex, study center, education, smoking and drinking level, and tertile of total caloric intake. There was a consistent pattern of protection for all sites (OR in the upper quartile ranging between 0.4 and 0.7), most notable for gastrointestinal neoplasms. All trends in risk were highly significant. The beneficial effect of raw tomatoes in this population may be partly due to the fact that they constitute perhaps the most specific feature of the Mediterranean diet. However, if it is true that tomatoes protect against digestive-tract cancers, this is of interest from both a scientific and a public health viewpoint. (C) 1994 Wiley-Liss, Inc.
- Published
- 1994
142. Alcohol and Cancers of the Upper Aerodigestive Tract in Men and Women
- Author
-
Franceschi, S., Ettore Bidoli, Negri, E., Barbone, F., Lavecchia, C., FRANCESCHI S, BIDOLI E, NEGRI E, BARBONE F, and LAVECCHIA C
- Subjects
Adult ,Male ,Alcohol Drinking ,Esophageal Neoplasms ,Smoking ,Pharyngeal Neoplasms ,Middle Aged ,Logistic Models ,Head and Neck Neoplasms ,Risk Factors ,Case-Control Studies ,mental disorders ,Confidence Intervals ,Odds Ratio ,Humans ,Female ,Mouth Neoplasms ,Sex Distribution ,Laryngeal Neoplasms ,Aged - Abstract
In order to explore the potential differences in the effect of alcohol in men and women we took advantage of a case-control study of upper aerodigestive tract tumors conducted between 1986 and 1991 in Northern Italy. Five hundred forty-six incident cases of cancer of the oral cavity and pharynx (of whom 81 were women), 410 of cancer of the esophagus (of whom 67 were women), and 388 with cancer of the larynx, (of whom 19 were women) were interviewed. The control group included 2263 inpatients (of whom 557 were women) with acute conditions unrelated to alcohol and tobacco consumption. Among alcohol drinkers, similar odds ratios were detected in men and women. In the highest, well comparable intake category (i.e., greater-than-or-equal-to 42 drinks/week in women and 42-55 drinks/week in men), odds ratios were 4.5 and 3.8 for cancer of the oral cavity and pharynx, 3.0 and 4.7 for cancer of the esophagus, and 2.6 and 2.0 for cancer of the larynx in women and men, respectively, as compared to light drinkers. However, for all cancer sites a reduced risk was found among abstaining women but not in abstaining men, when compared with light-to-moderate drinkers. The present study, therefore, does not support the hypothesis that women may be substantially more vulnerable than men to alcohol carcinogenesis, at least at the level of the upper aerodigestive tract. It highlights, however, the importance of the choice of the reference category (i.e., abstainers versus the combination of abstainers and light drinkers) in the comparison of risk estimates across population groups who greatly differ with respect to drinking patterns and other correlates of alcohol consumption.
143. The effects of antineoplastic chemotherapy on HIV disease
- Author
-
Emanuela Vaccher, M D'Andrea, Stefania Zanussi, Manola Comar, Cecilia Simonelli, Umberto Tirelli, Mauro Giacca, Ettore Bidoli, P. De Paoli, Zanussi, S, Simonelli, C, D'Andrea, M, Comar, Manola, Bidoli, E, Giacca, Mauro, Tirelli, U, Vaccher, E, and DE PAOLI, P.
- Subjects
Oncology ,Lymphoma ,analysis ,medicine.medical_treatment ,isolation /&/ purification ,HIV Core Protein p24 ,complications/drug therapy/immunology/virology, Multicenter Studies as Topic, Prednisone ,CHOP ,Antigens ,CD8 ,analysis, Antineoplastic Agents ,therapeutic use, CD4 Lymphocyte Count, Clinical Trials ,Phase III as Topic, Cyclophosphamide ,therapeutic use, Doxorubicin ,therapeutic use, Granulocyte Colony-Stimulating Factor ,therapeutic use, HIV Core Protein p24 ,genetics, HIV Seropositivity ,complications/immunology/virology, HIV-1 ,isolation /&/ purification, Humans, Lymphoma ,Non-Hodgkin ,therapeutic use, RNA ,Viral ,blood, Randomized Controlled Trials as Topic, Vincristine ,therapeutic use ,chemistry.chemical_compound ,immune system diseases ,Prednisone ,hemic and lymphatic diseases ,Granulocyte Colony-Stimulating Factor ,HIV Seropositivity ,polycyclic compounds ,Multicenter Studies as Topic ,genetics ,Randomized Controlled Trials as Topic ,Lymphoma, Non-Hodgkin ,therapeutic use, CD4 Lymphocyte Count, Clinical Trial ,Nitrogen mustard ,Phase III as Topic ,Infectious Diseases ,Vincristine ,Antigen ,RNA, Viral ,complications/drug therapy/immunology/virology ,medicine.drug ,analysis, Antineoplastic Agent ,medicine.medical_specialty ,Cyclophosphamide ,CD8 Antigens ,Immunology ,Antineoplastic Agents ,blood ,Virology ,Internal medicine ,medicine ,Humans ,Clinical Trials ,Doxorubicin ,complications/immunology/virology ,Chemotherapy ,business.industry ,medicine.disease ,CD4 Lymphocyte Count ,chemistry ,Clinical Trials, Phase III as Topic ,HIV-1 ,RNA ,business - Abstract
Six patients with human immunodeficiency virus (HIV)-associated non-Hodgkin lymphoma receiving chemotherapy (CT) with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) plus granulocyte colony-stimulating factor were sequentially monitored to study the effects of these treatments on their immunologic status (CD4 and CD8 cell counts) and on HIV plasma viremia. We show that mean CD4 cell counts declined significantly after the third cycle of CT (187 +/- 117/microliters before CT versus 92.4 +/- 60/microliters; p = 0.04) and remained significantly reduced 4 months after completion of CT. Modifications of CD8 cell counts were not statistically significant. The effects of CT on plasma viremia, as measured by a competitive polymerase chain reaction technique, were delayed until the fourth cycle, when an increase of viral load ranging from 0.6 to 2 logs (p = 0.027) was observed. After this point, viremia returned to baseline levels, with the exception of two patients who later developed opportunistic infections and one who underwent disease progression. These results suggest that, contrary to CD4 cell counts, plasma viremia could be a faithful surrogate marker for monitoring of HIV disease progression in patients undergoing CT.
144. Smoking and Drinking in Relation to Cancers of the Oral Cavity, Pharynx, Larynx, and Esophagus in Northern Italy
- Author
-
Franceschi, S., Talamini, R., Barra, S., Baron, Ae, Negri, E., Ettore Bidoli, Serraino, D., Lavecchia, C., FRANCESCHI S, TALAMINI R, BARRA S, BARON AE, NEGRI E, BIDOLI E, SERRAINO D, and LAVECCHIA C
- Subjects
Adult ,Male ,Risk ,Alcohol Drinking ,Esophageal Neoplasms ,Italy ,Smoking ,Humans ,Mouth Neoplasms ,Pharyngeal Neoplasms ,Middle Aged ,Laryngeal Neoplasms ,Aged - Abstract
A hospital-based case-control study of upper aerodigestive tract tumors was conducted between June 1986 and June 1989 in Northern Italy. One hundred fifty-seven male cases of oral cavity cancer, 134 of pharyngeal cancer, 162 of laryngeal cancer, and 288 of esophageal cancer, and 1272 male inpatients with acute conditions unrelated to tobacco and alcohol were interviewed. Odds ratios for current smokers of cigarettes were 11.1 for oral cavity, 12.9 for pharynx, 4.6 for larynx, and 3.8 for esophagus. For all 4 sites, the risk increased with increasing number of cigarettes and duration of smoking habits and, with the exception of esophageal cancer, decreased with increasing age at the start of and years since quitting smoking. Smokers of pipes and cigars showed a more elevated risk of cancer of the oral cavity and esophagus than did cigarette smokers. Significantly increased risks emerged also in heavy drinkers (odds ratio greater than 60 versus greater than or equal to 19 drinks/week = 3.4, 3.6, 2.1, and 6.0 for oral cavity, pharynx, larynx, and esophagus, respectively), deriving predominantly from wine consumption.
145. Patients with cancer who will be cured and projections of complete prevalence in Italy from 2018 to 2030.
- Author
-
Guzzinati S, Toffolutti F, Francisci S, De Paoli A, Giudici F, De Angelis R, Demuru E, Botta L, Tavilla A, Gatta G, Capocaccia R, Zorzi M, Caldarella A, Bidoli E, Falcini F, Bruni R, Migliore E, Puppo A, Ferrante M, Gasparotti C, Gambino ML, Carrozzi G, Bianconi F, Musolino A, Cavallo R, Mazzucco W, Fusco M, Ballotari P, Sampietro G, Ferretti S, Mangone L, Mantovani W, Mian M, Cascone G, Manzoni F, Galasso R, Piras D, Pesce MT, Bella F, Seghini P, Fanetti AC, Pinna P, Serraino D, Rossi S, and Dal Maso L
- Subjects
- Humans, Italy epidemiology, Female, Male, Prevalence, Aged, Middle Aged, Adult, Adolescent, Young Adult, Child, Aged, 80 and over, Registries, Cancer Survivors statistics & numerical data, Child, Preschool, Infant, Forecasting, Infant, Newborn, Neoplasms epidemiology, Neoplasms therapy
- Abstract
Background: The number and projections of cancer survivors are necessary to meet the healthcare needs of patients, while data on cure prevalence, that is, the percentage of patients who will not die of cancer by time since diagnosis, are lacking., Materials and Methods: Data from Italian cancer registries (duration of registration ranged from 9 to 40 years, with a median of 22 years) covering 47% of the population were used to calculate the limited-duration prevalence, the complete prevalence in 2018, projections to 2030, and cure prevalence, by cancer type, sex, age, and time since diagnosis., Results: A total of 3 347 809 people were alive in Italy in 2018 after a cancer diagnosis, corresponding to 5.6% of the resident population. They will increase by 1.5% per year to 4 012 376 in 2030, corresponding to 6.9% of the resident population, 7.6% of women and ∼22% after age 75 years. In 2030, more than one-half of all prevalent cases (2 million) will have been diagnosed by ≥10 years. Those with breast (1.05 million), prostate (0.56 million), or colorectal cancers (0.47 million) will be 52% of all prevalent patients. Cure prevalence was 86% for all patients alive in 2018 (87% for patients with breast cancer and 99% for patients with thyroid or testicular cancer), increasing with time since diagnosis to 93% for patients alive after 5 years and 96% after 10 years. Among patients who survived at least 5 years, the excess risk of death (1 - cure prevalence) was <5% for patients with most cancer types except for those with cancers of the breast (8.3%), lung (11.1%), kidney (13.2%), and bladder (15.5%)., Conclusions: Study findings encourage the implementation of evidence-based policies aimed at improving long-term clinical follow-up and rehabilitation of people living after cancer diagnosis throughout the course of the disease. Updated estimates of complete prevalence are important to enhance data-driven cancer control planning., (Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
146. Early Onset of Lung Cancer in Small Areas as a Signature of Point Pollution Sources.
- Author
-
Bidoli E
- Abstract
The impact of air pollution on lung cancer (LC) is difficult to detect in low-populated areas due to the potentially unfocused detection of pollutants and/or limited statistical power. This study identified and measured the harmful effect of pollution in small areas by considering the early onset of LC as a signature of pollution. This novel method requires a Bayesian standard curve calculated from the median age at LC onset and the corresponding median age of reference populations. Similar medians gathered from the area/s under investigation permits a probabilistic comparison with the standard curve. Statistically significant divergences can be interpreted as early or late LC onset. The method is exemplified in the Trieste municipality (northeast Italy) using data from the Friuli Venezia Giulia Cancer Registry (study population) and from the International Agency for Research on Cancer (reference population). Early LC onset has been observed near the pollution sources. Within 600 m of the iron foundry, onset ranged between 3.2 and 7.7 years earlier in men and between 11.7 and 16.8 years earlier in women. Near the shipyard, early onset was around 4 years in men and 7 years in women, while in the industrial area, early onset was 5 years in women only. Examining early LC onset may speed up the investigation of potential environmental hazards.
- Published
- 2024
- Full Text
- View/download PDF
147. The descriptive epidemiology of melanoma in Italy has changed - for the better.
- Author
-
Bucchi L, Mancini S, Crocetti E, Dal Maso L, Baldacchini F, Vattiato R, Giuliani O, Ravaioli A, Zamagni F, Bella F, Bidoli E, Caldarella A, Candela G, Carone S, Carrozzi G, Cavallo R, Ferrante M, Ferretti S, Filiberti RA, Fusco M, Gatti L, Gili A, Iacovacci S, Magoni M, Mangone L, Mazzoleni G, Michiara M, Musolino A, Piffer S, Piras D, Rizzello RV, Rosso S, Rugge M, Scala U, Stracci F, Tagliabue G, Toffolutti F, Tumino R, Biggeri A, Masini C, Ridolfi L, Villani S, Palmieri G, Stanganelli I, and Falcini F
- Subjects
- Male, Humans, Female, Italy epidemiology, Biopsy, Immune Checkpoint Inhibitors, Molecular Targeted Therapy, Melanoma epidemiology
- Abstract
A recent research project using data from a total of 40 cancer registries has provided new epidemiologic insights into the results of efforts for melanoma control in Italy between the 1990s and the last decade. In this article, the authors present a summary and a commentary of their findings. Incidence increased significantly throughout the study period in both sexes. However, the rates showed a stabilization or a decrease in men and women aged below 35 years. The risk of disease increased for successive cohorts born until 1973 (women) and 1975 (men) while subsequently tending to decline. The trend towards decreasing tumor thickness and increasing survival has continued, but a novel favorable prognostic factor has emerged since 2013 for patients - particularly for males - with thick melanoma, most likely represented by molecular targeted therapies and immune checkpoint inhibitors. Due to this, the survival gap between males and females has been filled out. In the meanwhile, and despite the incidence increase, dermatologists have not lowered their threshold to perform skin biopsy. Skin biopsy rate has increased because of the increasingly greater volume of dermatologic office visits, but the proportion of skin biopsies out of dermatologic office visits has remained constant. In summary, an important breakthrough in melanoma control in Italy has taken place. Effective interventions have been implemented across the full scope of care, which involve many large local populations - virtually the whole national population. The strategies adopted during the last three decades represent a valuable basis for further steps ahead in melanoma control in Italy.
- Published
- 2023
- Full Text
- View/download PDF
148. Breast cancer deaths attributable to alcohol consumption: Italy, 2015-2019.
- Author
-
Driutti M, Dal Maso L, Toffolutti F, Valdi G, Bidoli E, Giudici F, Parpinel M, and Serraino D
- Subjects
- Humans, Female, Alcohol Drinking adverse effects, Alcohol Drinking epidemiology, Italy epidemiology, Risk, Risk Factors, Breast Neoplasms
- Abstract
A study was conducted to assess the fraction of female breast cancer (BC) deaths attributable to alcohol consumption in Italy. National mortality data for the period 2015-2019 were used along with national estimates of women from the general population exposed to moderate (11-20 gr/day) or heavy (>20 gr/day) alcohol consumption. From 2015 to 2019, 2918 (4.6%) out of 63,428 BC| deaths were attributable to alcohol consumption, including 1269 deaths (2.0%) caused by moderate consumption. Study findings could help stakeholders to prioritize programs aimed at reducing alcohol consumption, and to improve ways to effectively communicate alcohol-related health risks, including moderate consumption., Competing Interests: Declaration of competing interest All Authors declare that they have no conflicts of interest., (Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
149. The use of PSA testing over more than 20 years: A population-based study in North-Eastern Italy.
- Author
-
Taborelli M, Toffolutti F, Bidoli E, Dal Maso L, Del Zotto S, Clagnan E, Gobbato M, Serraino D, and Franceschi S
- Subjects
- Humans, Male, Aged, Middle Aged, Prostate pathology, Italy epidemiology, Biopsy, Prostate-Specific Antigen, Prostatic Neoplasms diagnosis, Prostatic Neoplasms epidemiology, Prostatic Neoplasms pathology
- Abstract
Objective: To describe the practice of prostate-specific antigen (PSA) testing over more than 20 years in Friuli Venezia Giulia (FVG), North-Eastern Italy., Methods: A population-based, ecological study was conducted using information derived from regional administrative health-related databases. Data on PSA and prostate biopsies performed on resident men aged ⩾45 years from 1998 to 2019 were retrieved. PSA and biopsy rates were calculated as the number of men who had at least one such procedure in each calendar year over the mean resident male population of the same year. Temporal trends were analyzed using joinpoint regression (annual percentage change -APC)., Results: A total of 2,502,670 PSA were made between 1998 to 2019 in men aged ⩾45 years. The number of PSA steadily increased from 51,055 in 1998-1999 to 134,504 in 2010-2011, then dropped to 122,080 in 2018-2019. Significant changes in the slopes of PSA rates emerged in 2002 and 2009: the largest increase occurred during 1998-2002 (APC 18.4), followed by a smaller increase in 2002-2009 (APC 3.4) and a subsequent reduction (APC -2.5). Similar patterns emerged for all ages, but the decrease since 2009 was smaller for men aged ⩾65 years. An upward trend emerged in biopsy rate from 1998 to 2001 (APC 13.0), followed by a smaller increase until 2007 (APC 5.7) and a subsequent decrease. Biopsies as percentage of PSA decreased from 3.2% to 2.2%, particularly in those aged ⩾75 years., Conclusions: Although overall declining PSA rates have been observed in FVG since 2009, rates remained higher in the ⩾65-year-old group than in the 45-64-year-old group.
- Published
- 2023
- Full Text
- View/download PDF
150. Complete prevalence and indicators of cancer cure: enhanced methods and validation in Italian population-based cancer registries.
- Author
-
Toffolutti F, Guzzinati S, De Paoli A, Francisci S, De Angelis R, Crocetti E, Botta L, Rossi S, Mallone S, Zorzi M, Manneschi G, Bidoli E, Ravaioli A, Cuccaro F, Migliore E, Puppo A, Ferrante M, Gasparotti C, Gambino M, Carrozzi G, Stracci F, Michiara M, Cavallo R, Mazzucco W, Fusco M, Ballotari P, Sampietro G, Ferretti S, Mangone L, Rizzello RV, Mian M, Cascone G, Boschetti L, Galasso R, Piras D, Pesce MT, Bella F, Seghini P, Fanetti AC, Pinna P, Serraino D, and Dal Maso L
- Abstract
Objectives: To describe the procedures to derive complete prevalence and several indicators of cancer cure from population-based cancer registries., Materials and Methods: Cancer registry data (47% of the Italian population) were used to calculate limited duration prevalence for 62 cancer types by sex and registry. The incidence and survival models, needed to calculate the completeness index ( R ) and complete prevalence, were evaluated by likelihood ratio tests and by visual comparison. A sensitivity analysis was conducted to explore the effect on the complete prevalence of using different R indexes. Mixture cure models were used to estimate net survival (NS); life expectancy of fatal (LEF) cases; cure fraction (CF); time to cure (TTC); cure prevalence, prevalent patients who were not at risk of dying as a result of cancer; and already cured patients, those living longer than TTC at a specific point in time. CF was also compared with long-term NS since, for patients diagnosed after a certain age, CF (representing asymptotical values of NS) is reached far beyond the patient's life expectancy., Results: For the most frequent cancer types, the Weibull survival model stratified by sex and age showed a very good fit with observed survival. For men diagnosed with any cancer type at age 65-74 years, CF was 41%, while the NS was 49% until age 100 and 50% until age 90. In women, similar differences emerged for patients with any cancer type or with breast cancer. Among patients alive in 2018 with colorectal cancer at age 55-64 years, 48% were already cured (had reached their specific TTC), while the cure prevalence (lifelong probability to be cured from cancer) was 89%. Cure prevalence became 97.5% (2.5% will die because of their neoplasm) for patients alive >5 years after diagnosis., Conclusions: This study represents an addition to the current knowledge on the topic providing a detailed description of available indicators of prevalence and cancer cure, highlighting the links among them, and illustrating their interpretation. Indicators may be relevant for patients and clinical practice; they are unambiguously defined, measurable, and reproducible in different countries where population-based cancer registries are active., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Toffolutti, Guzzinati, De Paoli, Francisci, De Angelis, Crocetti, Botta, Rossi, Mallone, Zorzi, Manneschi, Bidoli, Ravaioli, Cuccaro, Migliore, Puppo, Ferrante, Gasparotti, Gambino, Carrozzi, Stracci, Michiara, Cavallo, Mazzucco, Fusco, Ballotari, Sampietro, Ferretti, Mangone, Rizzello, Mian, Cascone, Boschetti, Galasso, Piras, Pesce, Bella, Seghini, Fanetti, Pinna, Serraino, Dal Maso and AIRTUM Working Group.)
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.